Publications by authors named "Hugh Lin"

Claim this Profile
T
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Arshad M Khanani, Aachal Kotecha, Andrew Chang, Shih-Jen Chen, Youxin Chen, Hugh Lin

Ophthalmology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy.
Neil M Bressler, K Bailey Freund, Sophie J Bakri, Judy E Kim, Daniela Ferrara, Hugh Lin

JAMA Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Tien Y Wong, Zdenka Haskova, Kemal Asik, Caroline R Baumal, Karl G Csaky, Hugh Lin

Ophthalmology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials.
Kanji Takahashi, Chui Ming Gemmy Cheung, Tomohiro Iida, Timothy Y Y Lai, Masahito Ohji, Hugh Lin

Graefes Arch Clin Exp Ophthalmol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.
Nicole Eter, Rishi P Singh, Francis Abreu, Kemal Asik, Karen Basu, Caroline Baumal, Hugh Lin

Ophthalmol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Jeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, Karen Basu, Philip J Ferrone, Hugh Lin

Lancet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Charles C Wykoff, Francis Abreu, Anthony P Adamis, Karen Basu, David A Eichenbaum, Hugh Lin

Lancet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.
Arshad M Khanani, Robyn H Guymer, Karen Basu, Heather Boston, Jeffrey S Heier, Hugh Lin

Ophthalmol Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
Nancy Holekamp, Charles C Wykoff, Steffen Schmitz-Valckenberg, Jordi Monés, Eric H Souied, Hugh Lin

Ophthalmology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microperimetry for geographic atrophy secondary to age-related macular degeneration.
Karl G Csaky, Praveen J Patel, Yasir J Sepah, David G Birch, Diana V Do, Hugh Lin

Surv Ophthalmol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Christopher Lievens, Gregg Berdy, David Douglass, Stephen Montaquila, Hugh Lin

Cont Lens Anterior Eye· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.
Avi Wallerstein, W Bruce Jackson, Jeffrey Chambers, Amir M Moezzi, Hugh Lin

Clin Ophthalmol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glaucoma screening using relative afferent pupillary defect.
Resmi A Charalel, Hugh S Lin, Kuldev Singh

J Glaucoma· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axial length does not correlate with degree of visual field loss in myopic Chinese individuals with glaucomatous appearing optic nerves.
Daniel Lee Chao, Anurag Shrivastava, Donna H Kim, Hugh Lin, Kuldev Singh

J Glaucoma· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis